27 results on '"Munshi, Nikhil C."'
Search Results
2. A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation
3. A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events
4. Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide
5. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop
6. A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma
7. Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders
8. Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications
9. Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo
10. In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465
11. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor
12. Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma
13. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells
14. Long-term outcome results of the first tandem autotransplant trial for multiple myeloma
15. Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib
16. In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells
17. FQPD, a novel immunomodulatory drug, has significant in vitro activity in multiple myeloma
18. Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma
19. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma
20. Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma
21. Anti-myeloma activity of pamidronate in vivo
22. A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma
23. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop
24. In vitroanti-myeloma activity of the Aurora kinase inhibitor VE-465
25. In vivoanti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor
26. Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo.
27. Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.